# The Impact of RPh201 on CVS Patients: Clinical and fMRI Measurements

> **NCT01417299** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Hadassah Medical Organization**

## Conditions studied

- Chronic Vegetative State

## Interventions

- **DIETARY_SUPPLEMENT:** RPh201
- **DIETARY_SUPPLEMENT:** saline

## Key facts

- **NCT ID:** NCT01417299
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-10
- **Primary completion:** 2017-10
- **Final completion:** 2018-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This record is an additional copy of the study listed above
- **Last updated:** 2015-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01417299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01417299, "The Impact of RPh201 on CVS Patients: Clinical and fMRI Measurements". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01417299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
